Mitochondrial biogenesis is the cellular process of producing new mitochondria, the organelles that handle most aerobic energy production in human cells. In Unfair, mitochondrial biogenesis is a mechanism term that explains why some training and supplement stories are interesting; it is not a number a user can read at home, and it is not a guarantee of longevity or performance.
What the term actually describes
Mitochondrial biogenesis is studied through cellular and animal models, plus some human muscle-biopsy work in athletic populations. A consumer device cannot show mitochondrial biogenesis directly. The mechanism of action label is therefore the right place to file the concept inside a stack.
The most reliable real-world driver of mitochondrial adaptation is sustained aerobic and resistance training over months, not a supplement. That context belongs in any honest mitochondrial story.
Where the term shows up
Many supplements list mitochondrial biogenesis as a feature, sometimes including creatine, resveratrol, and urolithin a. The pillar complete guide to supplement stacks is the relevant frame, because the user's actual review will still depend on tracked proxies like training output, recovery, perceived energy, and possibly a vo2 max estimate trend.
A mechanism claim is not a proxy. The stack still has to be reviewed on what changed for the user.
Limits of the claim
Mitochondrial biogenesis does not guarantee longevity, does not reverse aging, and is not a clinical endpoint. A product label that links a supplement to mitochondrial biogenesis is describing a hypothesis, not a guaranteed personal outcome. Many supplement studies use cell or animal models that do not translate cleanly to people.
A stack that adds three mitochondrial supplements in the same week will struggle to attribute any change. One item at a time, with a defined block, is a more readable design.
How this appears in Unfair
In Unfair, mitochondrial biogenesis can appear as a mechanism note on certain items. The review still uses training, recovery, sleep, adherence, and any objective proxies the user logs.
Clinical safety note
Symptoms such as chest pain, fainting, unexplained fatigue, or persistent muscle weakness are not signals that a mitochondrial protocol is working. They move the question out of stack review and into clinical review.